Globus Medical GMED
NYSE GMED
$78.69 -0.27 (-0.34%)
As of: Oct 21, 2026 · 3:59 PM EDT

Globus Medical (GMED) Convertible Debt (2023)

Updated

Globus Medical (GMED) posted Convertible Debt of $417.4 million for Q4 2023, up 1.9% from the prior quarter.

Analysis

Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Globus Medical 10.62 Bn 8.45 Bn 548.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 417.40 Mn
Sep 30, 2023 409.72 Mn
API Access

Globus Medical Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GMED&period=max&api_key=YOUR_API_KEY